AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion

[riky]

AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion

<p><a href="http://news.yahoo.com/astrazeneca-buys-lung-drug-firm-pearl-1-15-061616773.html"><img src="http://l2.yimg.com/bt/api/res/1.2/Vo7.QP9CIDKo3AiRw_6.0Q--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-10T142259Z_1_CBRE95913YE00_RTROPTP_2_ASTRAZENECA.JPG" width="130" height="86" alt="A worker leaves the AstraZeneca research facility in Loughborough" align="left" title="A worker leaves the AstraZeneca research facility in Loughborough" border="0" /></a>By Ben Hirschler LONDON (Reuters) - AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion as Britain's second biggest drugmaker steps up a drive to rebuild its product pipeline via deal-making. The acquisition of the privately held company secures AstraZeneca a position in the emerging market for a new class of lung treatments known as LABA/LAMA drugs that promise improved patient compliance and disease control, without steroids. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login